Focus on Pharma Verification Authentag's development and sale of the Verification Router Service (VRS), which enables FDA-authorized trading parties to verify pharmaceuticals directly with manufacturers, indicates a strong niche in pharmaceutical supply chain security. Companies involved in drug manufacturing, distribution, or compliance would benefit from similar verification solutions, presenting opportunities for resale, licensing, or customized security tech.

Decentralized Finance Innovation The company’s collaboration on decentralized financial (DeFi) systems aimed at optimizing trade finance suggests potential for engaging with firms seeking to streamline trade finance processes, especially in supply chains or international trade sectors looking for transparency and efficiency improvements.

Technology Stack Leverage AuthenTAg's use of cloud-based and modern libraries such as Google Cloud and Bootstrap highlights its technical capabilities. This expertise could be leveraged to introduce infrastructure upgrades or complementary IT solutions to clients in regulated industries that need scalable, secure, and innovative IT services.

Niche Market Focus Despite closing in early 2022, Authentag’s activity in specialized areas like pharma verification and trade finance points to a niche market focus that remains relevant. Sales efforts can target companies in regulatory compliance, security, and trade finance sectors that seek tailored digital verification or financial technology solutions.

Emerging Opportunities in Security and Trade The company’s engagement in developing unique verification services and decentralized financial systems signals ongoing demand for advanced security and trade finance solutions. Firms in regulatory-heavy industries or global trade companies exploring digital transformation are potential clients interested in similar innovations.